University of Texas MD Anderson Cancer Center

Development of a simple and robust whole blood assay with dual co-stimulation to quantify the release of t-cellular signature cytokines in response to aspergillus fumigatus antigens (2021) Lauruschkat CD, Page L, White PL, Etter S, Davies HE, Duckers J, Ebel F, et al. Journal article CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to Aspergillus fumigatus (2021) Page L, Wallstabe J, Lother J, Bauser M, Kniemeyer O, Strobel L, Voltersen V, et al. Journal article Proposed definition of competencies for surgical neuro-oncology training (2021) Kamp MA, Malzkorn B, von Sass C, DiMeco F, Hadjipanayis CG, Senft C, Rapp M, et al. Journal article Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors (2021) Franchi A, Thompson LD, Hernandez-Prera JC, Agaimy A, Williams MD, Mikkelsen LH, Bishop JA, et al. Journal article Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics? (2021) Vlahou A, Hallinan D, Apweiler R, Argiles A, Beige J, Benigni A, Bischoff R, et al. Journal article New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021) Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, et al. Journal article Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms (2021) Yao JC, Strosberg J, Fazio N, Pavel ME, Bergsland E, Ruszniewski P, Halperin DM, et al. Journal article Consensus on molecular imaging and theranostics in neuroendocrine neoplasms (2021) Ambrosini V, Kunikowska J, Baudin E, Bodei L, Bouvier C, Capdevila J, Cremonesi M, et al. Journal article, Review article Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2021) Dighe SG, Chen J, Yan L, He Q, Gharahkhani P, Onstad L, Levine DM, et al. Journal article Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution